Guanze Medical Information Industry (Holding) Co., Ltd. announced that FUNDE (HONG KONG) INVESTMENT HOLDINGS CO., LIMITED (“Funde HK”) has despatched a composite offer document to all independent shareholders, formally launching a mandatory unconditional cash offer for all issued shares not already owned or agreed to be acquired by Funde HK and its concert parties.
Key terms of the offer • Offer price: HK$0.25 in cash for each Guanze Medical share, matching the price paid for 699.16 million shares (73.60 % of issued capital) acquired from controlling shareholder Meng A Capital. • Premium/discount: the offer represents an 8.4 % discount to Guanze Medical’s audited NAV per share of HK$0.273 (31 Dec 2025) and a 92.7 % discount to the HK$3.41 closing price on 14 Apr 2026. • Maximum payout: assuming full acceptance of the remaining 250.84 million shares (26.40 % free float), the total cash consideration would be HK$62.71 million. Funde HK will finance the offer from internal resources. • Offer period: opens on 17 Apr 2026 and is scheduled to close at 4:00 p.m. on 8 May 2026, unless extended or revised. Payment will be despatched within seven business days of valid acceptance.
Background of the transaction • On 6 Feb 2026, Funde HK completed the purchase of 699.16 million shares from Meng A Capital at HK$0.25 per share for HK$174.79 million, triggering an obligation under the Takeovers Code to make an offer for the remaining shares. • Post-completion, Funde HK is the controlling shareholder with a 73.60 % stake; public shareholders hold 26.40 %.
Intentions post-acquisition • Funde HK states it will maintain Guanze Medical’s existing business of medical imaging film products and cloud services in Shandong Province, PRC, and has no present plan to materially alter operations, dispose of assets, or change board composition. • The new owner will conduct a strategic review and may consider future investments or disposals in accordance with Listing Rules, while aiming to preserve the company’s listing status and public float.
Shareholder actions • Independent shareholders wishing to accept must lodge completed forms with Computershare Hong Kong Investor Services by the 8 May deadline. • All acceptances are irrevocable; settlement cheques (net of 0.1 % stamp duty) will be mailed within seven business days after valid acceptance.
Timetable highlights • Offer opens: 17 Apr 2026 • Close of offer (unless extended): 8 May 2026 • Latest payment date: 19 May 2026
Advisers • Aristo Securities Limited – agent for Funde HK • Lego Corporate Finance – financial adviser to Funde HK • Yue Xiu Capital – financial adviser to Guanze Medical • SBI China Capital Hong Kong Securities – independent financial adviser to the Independent Board Committee
Independent shareholders are advised to review the composite document, the Independent Board Committee’s recommendation and the independent financial adviser’s opinion before taking action.
Comments